Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
Clinical trial NCT03532009 · TERMINATED
Trial details
- NCT number
- NCT03532009
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2020-05-22
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.